Dentsply Sirona (XRAY) announced that Aldo Denti has been appointed Executive Vice President and Chief Commercial Officer, CCO, effective October 6, 2025. Denti most recently served as Company Group Chairman, Global Orthopedics, at Johnson & Johnson (JNJ) Medtech.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Cautious Hold Rating on DENTSPLY SIRONA Amid Awaited Turnaround Evidence
- DENTSPLY SIRONA Approves Retention Award for Executives
- Hold Rating for DENTSPLY SIRONA Amid Strategic Retention of Wellspect and Focus on Core Dental Business Revitalization
- Dentsply Sirona Retains Wellspect Healthcare After Review
- Dentsply Sirona retains Wellspect Healthcare as portfolio business